The blood testing company named Daniel Guggenheim, JD, as chief compliance officer. Formerly, he served as an assistant general counsel at San Francisco-based McKesson.
Dave Wurtz, who previously served as an executive at Waltham, Mass.-based Thermo Fisher Scientific, was appointed vice president of regulatory and quality.
Theranos said its board of directors also created a compliance and quality committee.
Theranos came under fire last October when the Food and Drug Administration issued a lab inspection reports claiming the company had used an unapproved medical device and lacked proper quality control procedures, both of which jeopardized patient health and safety.
More articles on leadership:
11 hospitals with great customer service
CS Mott Children’s Hospital embraces Pokémon GO to raise kids’ energy
15 healthcare companies on Fortune’s Global 500 list
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.